Similar articles

• Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.

  Singh S, Gopal AK, Bahl VK. Singh S, et al. Indian Heart J. 2005 May-Jun;57(3):201-9. Indian Heart J. 2005. PMID: 16196176 No abstract available.
• Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.

  Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2. Circulation. 2004. PMID: 14757697
• Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.

  Antman EM. Antman EM. Am Heart J. 2003 Oct;146(4 Suppl):S18-22. doi: 10.1016/j.ahj.2003.09.001. Am Heart J. 2003. PMID: 14564302 Review.
• Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.

  Cantor WJ, Goodman SG, Cannon CP, Murphy SA, Charlesworth A, Braunwauld E, Langer A. Cantor WJ, et al. Am Heart J. 2005 Feb;149(2):275-83. doi: 10.1016/j.ahj.2004.05.055. Am Heart J. 2005. PMID: 15846265 Clinical Trial.
• Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS.

  Kereiakes DJ, Tcheng J, Fry ET, Bhatt DL, Bosker G, Diez JG, Ferguson JJ 3rd, Levine GN, Schaer GL, Zidar J; CATH Clinical Consensus Panel. Kereiakes DJ, et al. J Invasive Cardiol. 2003 Sep;15(9):536-53. J Invasive Cardiol. 2003. PMID: 12947218 Review. No abstract available.